November 12, 2024 13:03 Stock market live today: Marksans Pharma Q2 net profit soars to ₹63.20 crore, shares rise 1.89% ...

Marksans Pharma added 2.70% to Rs 296.80 after the company reported 15.8% increase in consolidated net profit to Rs 96.72 crore on 20.83% rise in revenue from operations to Rs 641.92 crore in Q2 FY25 ...

Indiamart Intermeshs subsidiary, Tradezeal Online entered into share purchase agreement to disinvest a 26% stake in Shipway Technology by way of sale of 4,088 Compulsorily Convertible Preference ...

Ashoka Buildcon, Zydus Life, Nykaa and other key companies are set to release Q2 earnings today. Here’s the Bloomberg-tracked ...

Marksans Pharma, Medplus Health Services, Minda Corporation, Samvardhana Motherson International, Natco Pharma, Nucleus ...

In the coming truncated week, the markets are expected to consolidate further with stock-specific action due to global ...

Sun Pharma has seen a positive price breakout, currently trading above its third resistance level (R3) with a price of Rs 1914.45, just above R3 at Rs 1913.03. Sun Pharma is currently priced at Rs ...

German drugmaker Dr Falk Pharma GmbH today announced completion of the acquisition of Kynos Therapeutics, a clinical stage biopharmaceutical company focusing on the development of novel KMO inhibitors ...

The market is seeing strong growth primarily driven by a growing population. (Image Credits: Pixabay) Emcure Pharmaceuticals Limited on Monday announced that it is set to cater to a growing ...

Trading window for the designated persons of Marksans Pharma Limited will remain closed from 1st July, 2024 until 48 hours after announcement of Unaudited Financial Results for the quarter ended ...

Strides Pharma reported Q2 FY25 net profit of ₹93 Crore, marking a recovery from a ₹131 Crore loss in the same quarter last year. Revenue for Q2 FY25 reached ₹1,201 Crore, reflecting a 20.2% ...